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Background and purpose   We have previously shown that early 
fracture callus of rat rib has viscoelastic and contractile proper-
ties resembling those of smooth muscle. The cells responsible for 
this contractility have been hypothesized to be myofibroblast-like 
in nature. In soft-tissue healing, force generated by contraction of 
myofibroblasts promotes healing. Accordingly, we tried to iden-
tify myofibroblast-like cells in early fibrous callus.
Animals and methods   Calluses from rat rib fractures were 
removed 7, 14, and 21 days after fracture and unfractured ribs 
acted as controls. All tissues were analyzed using qPCR and immu-
nohistochemistry. We analyzed expression of smooth muscle- and 
myofibroblast-associated genes and proteins including alpha 
smooth muscle actin (αSMA), non-muscle myosin, fibronectin 
extra domain A variant (EDA-fibronectin), OB-cadherin, con-
nexin-43, basic calponin (h1CaP), and h-caldesmon.
Results   In calluses at 7 days post-fracture, there were statis-
tically significant increases in expression of αSMA mRNA (2.5 
fold), h1CaP mRNA (2.1 fold), EDA-fibronectin mRNA (14 fold), 
and connexin-43 mRNA (1.8 fold) compared to unfractured ribs, 
and by 21 days post-fracture mRNA expression in calluses had 
decreased to levels approaching those in unfractured rib. Immu-
nohistochemistry of 7 day fibrous callus localized calponin, EDA-
fibronectin and co-immunolabeling of OB-cadherin and αSMA 
(thus confirming a myofibroblastic phenotype) within various cell 
populations. 
Interpretation   This study provides further evidence that early 
rat rib callus is not only smooth muscle-like in nature but also 
contains a notable population of cells that have a distinct myofi-
broblastic phenotype. The presence of these cells indicates that in 
vivo contraction of early callus is a mechanism that may occur in 
fractures so as to facilitate healing, as it does in soft tissue wound 
repair.

There is a growing body of evidence to indicate that early, 
soft fracture callus is smooth muscle-like in nature. The con-
tractile microfilament, alpha smooth muscle actin (αSMA), is 
abundantly expressed in early fibrous callus and is recognized 
as a marker of osteoprogenitor cell populations (Kinner et al. 
2002, Dooley et al. 2004, Kalajzic et al. 2008). Furthermore, 
recent findings from our laboratory suggest that this αSMA 
expression translates into functional smooth muscle-like pas-
sive viscoelastic and active contractile properties of early rat 
rib fracture callus (McDonald et al. 2009, 2011) 
We have previously speculated that the cells responsible 
for such contractile characteristics are myofibroblast-like 
(McDonald et al. 2011). Myofibroblasts are phenotypically 
intermediate between smooth muscle cells and fibroblasts, and 
have a well-documented role in facilitating wound contraction 
in healing of soft-tissue wounds (Gabbiani 2003, Desmouliere 
et al. 2005). At around 1 week after soft-tissue injury, fibro-
blastic stress fibers develop de novo expression of αSMA that 
enhances contractile force generated by cells (Darby et al. 
1990, Hinz et al. 2001, Hinz and Gabbiani 2003). Myofibro-
blasts have cell-cell and cell-matrix connections that facilitate 
transmission of this force between cells and to the granulation 
tissue matrix (Petridou and Masur 1996, Dugina et al. 2001, 
Hinz et al. 2004). 
Around 1 week after injury, new tissue formed during soft 
tissue healing or fracture healing mainly contains fibrous, 
granulation-like tissue matrices (McKibbin 1978, Singer and 
Clark 1999, Mandracchia et al. 2001). It is likely that myofi-
broblasts would also be abundant in early callus, but expres-
sion of αSMA does not conclusively indicate the presence of 
myofibroblasts (Hinz 2007). A variety of cells express αSMA, 
and further work using expression and co-expression of other 
markers is necessary to confirm this hypothesis (Hinz 2007, 
Eyden 2008). 
Although αSMA is the main phenotypic marker of myo-
fibroblasts, these cells also have other recognized intracellu-
lar structural proteins, including non-muscle myosin and the 
smooth muscle protein basic calponin (h1CaP) (Miettinen et 
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smooth muscle-associated proteins such as h-caldesmon 
(Miettinen et al. 1999, Eyden 2008). Extra domain A splice 
variant of fibronectin (EDA-fibronectin) is considered to be 
the best marker of myofibroblastic extracellular matrix, and 
is necessary for formation and function of myofibroblasts 
(Tomasek et al. 2002, Hinz 2007). Development of myofibro-
blastic cell-cell connections is characterized by expression of 
OB-cadherin and the gap junction protein connexin-43 (Petri-
dou and Masur 1996, Hinz et al. 2004). Despite these charac-
teristics, the only described means of conclusively identifying 
myofibroblasts by immunohistochemistry is to co-localize 
both αSMA and OB-cadherin within these cells (Hinz 2007).
If myofibroblast-like cells are present in healing frac-
ture callus, they may have a similar functional role to that 
described in soft-tissue healing. We have previously hypoth-
esized that osteoprogenitor cells in early, fibrous callus are 
myofibroblast-like in nature and that their contraction may 
generate production of tensile forces that favor osteoblasto-
genesis and thus healing (Nikolovski et al. 2003, McBeath 
et al. 2004, Woods and Beier 2006). No studies have conclu-
sively detected myofibroblasts in early, fibrous fracture callus. 
Thus, in the present study we investigated (1) gene expression 
of smooth muscle- and myofibroblast-associated markers in 
rat rib callus on days 7, 14, and 21 post-fracture and (2) the 
location of the protein products of a number of these genes in 
7-day callus using immunohistochemistry. 
Methods
Animals and rib fracture surgery
This project was approved by La Trobe University Animal 
Ethics Committee (approved December 13, 2007; registra-
tion number: AEC 04/11v3). Twenty-eight 16-week-old male 
Sprague-Dawley rats had their sixth rib fractured as previously 
described (Dooley et al. 2004). Briefly, they were anesthetized 
by intraperitoneal injection of a mixture of 20% xylazine and 
80% ketamine (0.1 mL/100 g body weight). An incision was 
made on the lateral aspect of the trunk and the sixth rib was 
located and then fractured approximately 2 cm from the verte-
bral column using a pair of fine scissors. The rats were killed 
with an overdose of CO2 7, 14, or 21 days after fracture. 
qPCR
Unfractured ribs and fracture calluses at 7, 14, and 21 days 
post-fracture were extracted and stored in RNAlater (Ambion, 
Austin, TX) at –80°C. RNA was extracted from samples as 
described previously (McDonald et al. 2011). Reverse tran-
scription was performed using the SuperScript First-Strand 
Synthesis System according to the manufacturer’s instruc-
tions (Invitrogen, Mulgrave, Victoria, Australia). Each target 
gene sequence was located using a PubMed genome sequence 
search (GenBank). Beacon Designer 2.0 software (Biosoft 
International, Palo Alto, CA) was used to design optimal for-
ward and reverse primer sequences (Table), which were made 
commercially (GeneWorks Pty Ltd., Adelaide, SA, Australia). 
Expression of smooth muscle- and myofibroblast-associated 
genes in unfractured ribs and calluses was measured using 
the iCycler iQ Multi-Color Real-Time PCR detection system 
(Bio-Rad, Hercules, CA) as described previously (McDonald 
et al. 2011). Using the 2-∆∆CT (Livak) method, levels of smooth 
muscle- and myofibroblast-associated gene expression were 
normalized to that of glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) relative to unfractured rib. 
Histology and immunohistochemistry
Seven day callus samples were prepared, cryosectioned, and 
stained as previously described, but with slight modifications 
(McDonald et al. 2011). For standard histological observa-
tion, some sections were stained routinely with 1% toluidine 
blue. For immunohistochemistry, primary antibodies con-
sisted of a 1:500 dilution of rabbit anti-CaP (recommended 
Primer sequences and melt temperatures (Tm) used in the experiment
Protein encoded   NCBI reference     Sequence (5’ - 3’)   Length  Tm
by gene        (bp)  (°C)
GAPDH  NM_017008.3  Sense  AGTTCAACGGCACAGTCAAGG 21  58
     Antisense  ACATACTCAGCACCAGCATCAC  22  58
aSMA  NM_031004.2  Sense  CCAGCCAGTCGCCATCAG  19 53
    Antisense GGAGCATCATCACCAGCAAAG  21  56
h1CaP  NM_031747.1  Sense  CAGGCAACTATCAGTCTACAG  21 52
    Antisense GAGCGTGTCACAGTGTTC  18  50
Connexin-43 AH003191.1  Sense  GCCCTGCCATAAGCCCTCTTG  21  58
    Antisense GTGACCGCCTGCCTACAACTTC 22  58
Non-muscle NM_031520.1  Sense  GTGAAGCCTCTCCTCCAAGTG  21  56
myosin    Antisense TCCGTTCCATCTCCTCAAGTTC  22  55
h-caldesmon AB049626.1  Sense  TGGAAGCAGAAGAACAAGAAC  21  52
    Antisense TTCAGCCTCCCTCCTCTC  18  52
EDA-fibronectin NM019143.1  Sense  GACTGTGTACTCAGAACCCG  20  54
   (nucleotides 5462-5578)  Antisense  ACAGGGTGACCTACTCAAGC  20  54Acta Orthopaedica 2012; 83 (1): 93–98  95
Gene expression
Mean expression of αSMA, h1CaP, EDA-fibronectin and 
connexin-43 mRNA was transiently upregulated in healing 
callus (Figures 1A–D). There was an increase in expression 
of mRNA encoding αSMA (2.5 fold; p < 0.05), h1CaP (2.1 
fold; p < 0.05), EDA-fibronectin (14 fold; p < 0.01), and con-
nexin-43 (1.8 fold; p < 0.05) in 7 day post-fracture callus com-
pared to unfractured rib, and by 21 days post-fracture mRNA 
expression of these genes in callus had decreased to levels 
approaching that of unfractured rib (Figures 1A–D). The 
mRNA expression ratios of non-muscle myosin and h-caldes-
mon were, however, similar to unfractured rib levels in 7 day 
callus and remained relatively constant throughout healing 
(Figures 1E–F). 
Histology and immunohistochemistry 
Toluidine blue-stained sections of 7 day fracture sites showed 
large numbers of osteoprogenitor cells within fibrous tissue 
that linked fracture ends together. Nearer to the ends of frac-
tures, both cartilage and new trabecular bone were present 
(Figure 2). By immunohistochemistry, we could detect smooth 
muscle-related and myofibroblast-related proteins but this was 
variable in osteoprogenitor cells and matrix of fibrous callus 7 
days after fracture. CaP-like immunoreactivity (LI) expression 
was moderate but consistent in most osteoprogenitor cells of 
callus (Figure 3A). EDA-fibronectin-LI was intense in some 
regions but it was weaker in other areas within callus (Figure 
3B). Intense staining of OB-cadherin-LI and αSMA-LI was 
evident throughout fibrous callus, but the patterns of immu-
nostaining were different for each (Figures 3C,D). Double 
immunostaining for OB-cadherin and αSMA revealed that 
a high proportion of osteoprogenitor cells showed an intense 
brown-orange fluorescence, which indicated a myofibroblastic 
characteristic. Some cells only had single immunostaining of 
either protein (Figure 3E) (results not shown for non-specific 
control sections).
Figure 1. Gene expression in unfractured rib and in 7, 14, and 21 day rib fracture callus 
of rat (n = 7 biological replicates), normalized to GAPDH relative to normal intact rib. 
Expression of αSMA mRNA (A), h1CaP mRNA (B), EDA-fibronectin mRNA (C), and 
connexin-43 mRNA (D) all increased at 7 days post-fracture compared to unfractured 
rib (*p < 0.05, **p < 0.01). By 21 days post-fracture, expression of both αSMA mRNA 
and connexin-43 mRNA in callus was less than 7 day expression (***p < 0.001, **p < 
0.01, respectively) and was similar to the levels in unfractured rib. The expression of non-
muscle myosin mRNA (E) and h-caldesmon mRNA (F) was not significantly different in 
unfractured rib and callus at any time point.
 
for detection of h1CaP and h3CaP) (Santa 
Cruz Biotechnology Inc., Santa Cruz, CA), 
a 1:400 dilution of mouse anti-EDA-fibro-
nectin (Santa Cruz), a 1:400 dilution of goat 
anti-OB-cadherin (Santa Cruz) and a 1:400 
dilution of rabbit anti-αSMA (Abcam, Cam-
bridge, UK). Cell nuclei were counterstained 
with DAPI (indicated by blue fluorescence). 
Appropriate biotinylated secondary antibody 
and streptavidin-Cy3 (red fluorescence) or 
streptavidin-FITC (yellow-green fluores-
cence) labeling was used (Sigma-Aldrich). 
A sequential, double stain protocol was used 
for detecting co-expression of αSMA and 
OB-cadherin (visualized as orange-brown 
fluorescence). Immunostained sections were 
examined under a fluorescent microscope and 
images were captured as previously described 
(McDonald et al. 2011). Non-specific con-
trols consisted of incubations omitting pri-
mary antibodies. 
Statistics
Non-parametric ANOVA (Kruskal-Wallis) 
with Dunn’s post test was used to assess dif-
ferences between gene expression ratios in 
7, 14, and 21 day callus and in unfractured 
rib. All data was expressed as mean (SE). A 
p-value of < 0.05 was considered statistically 
significant. We used the GraphPad InStat 3 
software package for Windows (GraphPad 
Software Inc., La Jolla, CA).
Results96  Acta Orthopaedica 2012; 83 (1): 93–98
Discussion
To our knowledge, this is the first paper to describe a smooth 
muscle- and myofibroblast-associated gene/protein expres-
sion profile in fracture callus at the early stages of fracture 
healing. We provide evidence that a high proportion of cells 
responsible for the smooth muscle-like properties of early rat 
rib callus are myofibroblast-like. Myofibroblasts are known to 
feature in early healing of soft tissue. 
We found upregulation of expression of mRNA for αSMA, 
h1CaP, EDA-fibronectin and connexin-43, which provides 
further evidence of the myofibroblastic nature of early callus. 
It should be noted that these genes are not exclusive to myofi-
broblasts, but our hypothesis is supported by the fact that myo-
fibroblasts are widely considered not to express the smooth 
muscle protein heavy (h)-caldesmon (Miettinen et al. 1999, 
Watanabe et al. 1999, Ceballos et al. 2000). The h-isoform 
of caldesmon is a smooth muscle-specific protein that inhib-
its actin-activated myosin ATPase activity (Smolock et al. 
2009). Our finding of stable h-caldesmon mRNA expression 
during fracture healing suggests that the proportion of fully 
differentiated smooth muscle cells (e.g. those associated with 
arterioles) remained at levels similar to those in unfractured 
rib. Furthermore, although a variety of cells—including fibro-
blasts and myofibroblasts—contain non-muscle myosin, the 
steady expression of non-muscle myosin during healing is 
a feature also commonly described in the differentiation of 
fibroblasts to myofibroblasts (Hinz et al. 2001, Follonier Cas-
tella et al. 2010). Taken together, these gene expression results 
suggest that myofibroblast-associated rather than smooth 
muscle-associated mRNA expression is transiently upregu-
lated during fracture healing. 
Our findings also suggest expression of myofibroblastic 
marker mRNA translated to protein expression in early callus 
fibrous regions. Researchers mainly use αSMA as a marker 
for myofibroblasts; however, this protein is not exclusive to 
myofibroblasts as both smooth muscle cells and pericytes also 
express this isoform of actin (Park et al. 1997, Eyden 2008). 
Myofibroblasts, however, are the only cells that express both 
OB-cadherin and αSMA (Hinz 2007); thus, co-immunolocal-
ization of these 2 proteins in our experiments provides evi-
dence of myofibroblasts in early callus.
It remains to be seen whether all healing long bone fracture 
calluses contain myofibroblasts or whether this is unique to 
healing rib callus. Formation and function of myofibroblasts 
is dependent on both molecular factors and the local mechani-
cal environment. Specifically, myofibroblasts are considered 
to work best in environments with high tensile stress (Goffin 
et al. 2006, Wipff and Hinz 2009). We hypothesize that the 
constant mechanical stress placed on rib callus during breath-
ing may indeed provide the appropriate mechanical stimuli 
required for myofibroblastic function. Future investigations 
will analyze expression of myofibroblastic markers in frac-
tures with different mechanical environments. 
We found that transient upregulation in myofibroblastic 
marker mRNA expression in calluses was followed by a return 
to unfractured rib levels at 14 and 21 days post-fracture, which 
suggests that myofibroblasts become reduced in number as 
callus matures. This finding is consistent with studies on non-
fibrotic soft tissue healing where myofibroblasts were thought 
to disappear by apoptosis at around 16–25 days after injury 
(Desmouliere et al. 1995). We propose that these cells pre-
dominate in early rat rib fracture callus and at this point have 
a function similar to that seen in soft tissue healing, namely as 
a tension-generating cell. Having previously shown that early 
callus is capable of actively contracting ex vivo, we suggest 
that contraction of callus myofibroblasts in vivo may generate 
additional tensile forces in callus, similar to those proposed in 
soft tissue wound healing. Such intracellular tension and frac-
ture matrix tension is thought to favor differentiation of osteo-
progenitor cells toward an osteoblastic lineage rather than a 
chondrocytic one (McBeath et al. 2004, Arnsdorf et al. 2009, 
Morgan et al. 2010). Thus, a myofibroblast-like osteoprogeni-
tor cell may be a possible therapeutic target for accelerating 
healing. 
Basic calponin (h1Cap) is an actin-associated protein with 
a minor regulatory role in smooth muscle contraction (Yoshi-
kawa et al. 1998, Matthew et al. 2000). There is also evidence 
that expression of h1CaP has a non-contractile biological role 
in regulation of actin cytoskeleton stability (Matthew et al. 
2000, Rozenblum and Gimona 2008). We believe that early, 
contractile callus is likely to be impeded from forming bone 
due to the presence of smooth muscle proteins such as h1CaP. 
Mice lacking the gene for h1CaP show increased bone forma-
tion and accelerated bone fracture healing (Yoshikawa et al. 
1998). Given this information, as well as the data presented 
Figure 2. A low-power micrograph of a toluidine blue stained histologi-
cal section of a rat rib fracture site after 7 days, showing a significant 
amount of soft-tissue collagenous matrix containing osteoprogenitor 
cells (arrows) linking together two ends (E) of fractured rib. Immuno-
histochemical analyses were performed in these fibrous tissue regions. 
Newly formed cartilage (C) and trabecular bone (B) within the callus 
are also evident. (M: skeletal muscle). Magnification: ×25. Acta Orthopaedica 2012; 83 (1): 93–98  97
in the current experiments, we propose that upregulation of 
h1CaP in early, contractile callus is likely to inhibit callus 
bone formation and that the subsequent downregulation of 
h1CaP in callus over the ensuing weeks may thereby facilitate 
osteogenesis of callus.
In conclusion, our study provides evidence that myofibro-
blast-like cells are present in healing rat rib fracture callus. 
Transient upregulation of expression of genes encoding cer-
tain myofibroblastic makers, together with prominent immu-
nostaining for myofibroblasts in callus fibrous regions, sug-
gests that a population of early callus osteoprogenitor cells are 
myofibroblast-like in nature. Thus, these cells possibly have a 
role in fracture healing that is similar to what they have in soft 
tissue wound healing.
SJM: all experiments, and manuscript writing. PCD: experimental design and 
manuscript editing. ACM: qPCR and manuscript editing. JAS: experimental 
design, surgery, qPCR, and manuscript editing. ARW: statistical analysis and 
manuscript editing. BLG: experimental design, surgery, immunohistochemis-
try, and writing and editing of manuscript.
 
Figure 3. Immunohistochemistry of fibrous callus linking fracture ends in a rat rib 
fracture after 7 days. Panels C–E show immunostaining of the same callus section. 
Cell nuclei for panels A–E were stained with DAPI (blue). 
A. Osteoprogenitor cells show consistent but moderate CaP-LI (indicated by red fluo-
rescence). 
B. There is intense EDA-fibronectin-like immunoreactivity (LI) (indicated by red fluo-
rescence) in some regions of callus; other areas show only moderate EDA-fibro-
nectin-LI immunostaining. 
C. OB-cadherin-LI in osteoprogenitor cells (indicated by yellow-green fluorescence). 
OB-cadherin-LI is particularly intense in high-density fibrous regions (left of pic-
ture). Not all cells are OB-cadherin-positive, however. 
D. Osteoprogenitor cells to the left contain significant αSMA-LI (indicated by red fluo-
rescence), but the cells to the right show only moderate αSMA-LI. 
E.  A sequentially immunostained section for αSMA (red fluorescence) and OB-
cadherin (yellow-green fluorescence). Co-localization of these two proteins by 
immunohistochemistry resulted in a combined brown-orange fluorescence, which 
is mainly located in osteoprogenitor cells to the left of this micrograph. Note that 
some cells only show either αSMA-LI or OB-cadherin-LI. Magnification: ×200; 
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